top of page
A L T I T U D E
Life Science Ventures
Companies in the News
Oct 25
Tessera Therapeutics Presents New Preclinical Data in In Vivo AATD and SCD Programs at the 31st Annual Congress of the European Society of Gene and Cell Therapy
A single intravenous administration of Gene Writer™ resulted in an estimated 79% hepatocyte genomic editing with an average of 84% of...
Oct 9
Startup led by John Maraganore raises $135M to build ‘future of RNAi’
Since stepping down as CEO of Alnylam Pharmaceuticals three years ago, John Maraganore has lent his talents widely, joining the boards of...
bottom of page